Bank of New York Mellon Corp Cuts Stock Position in TherapeuticsMD Inc (NASDAQ:TXMD)

The fund owned 21,149,690 shares of the company’s stock after selling 2,994,936 shares during the period. Bank of New York Mellon Corp owned …

TherapeuticsMD logoBank of New York Mellon Corp lessened its stake in TherapeuticsMD Inc (NASDAQ:TXMD) by 12.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 21,149,690 shares of the company’s stock after selling 2,994,936 shares during the period. Bank of New York Mellon Corp owned 8.77% of TherapeuticsMD worth $54,990,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently bought and sold shares of TXMD. Moors & Cabot Inc. purchased a new position in TherapeuticsMD in the second quarter valued at about $25,000. Moloney Securities Asset Management LLC purchased a new position in TherapeuticsMD in the second quarter valued at about $27,000. H D Vest Advisory Services purchased a new position in TherapeuticsMD in the second quarter valued at about $34,000. Advisor Group Inc. grew its stake in TherapeuticsMD by 73.2% in the second quarter. Advisor Group Inc. now owns 13,960 shares of the company’s stock valued at $36,000 after purchasing an additional 5,900 shares during the last quarter. Finally, Aperio Group LLC grew its stake in TherapeuticsMD by 87.0% in the second quarter. Aperio Group LLC now owns 29,593 shares of the company’s stock valued at $77,000 after purchasing an additional 13,771 shares during the last quarter. Institutional investors own 78.88% of the company’s stock.

Shares of NASDAQ TXMD opened at $3.42 on Friday. The company has a debt-to-equity ratio of 24.29, a quick ratio of 4.99 and a current ratio of 5.17. The company has a market cap of $824.98 million, a PE ratio of -5.80 and a beta of 1.70. The business has a 50-day simple moving average of $2.67 and a two-hundred day simple moving average of $3.56. TherapeuticsMD Inc has a fifty-two week low of $1.82 and a fifty-two week high of $6.94.

TherapeuticsMD (NASDAQ:TXMD) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.01). The business had revenue of $6.08 million during the quarter, compared to analyst estimates of $5.12 million. TherapeuticsMD had a negative return on equity of 212.57% and a negative net margin of 913.07%. TherapeuticsMD’s revenue was up 60.0% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.15) EPS. On average, sell-side analysts predict that TherapeuticsMD Inc will post -0.73 earnings per share for the current fiscal year.

Several equities analysts have issued reports on TXMD shares. Cantor Fitzgerald reiterated an “overweight” rating and issued a $13.00 target price on shares of TherapeuticsMD in a research note on Wednesday, August 7th. Jefferies Financial Group cut their target price on TherapeuticsMD from $4.00 to $3.00 and set a “hold” rating on the stock in a research note on Monday, July 15th. Cowen cut their target price on TherapeuticsMD from $16.00 to $9.00 and set an “outperform” rating on the stock in a research note on Tuesday, June 11th. Noble Financial reiterated a “buy” rating and issued a $13.00 target price on shares of TherapeuticsMD in a research note on Monday, August 12th. Finally, JPMorgan Chase & Co. cut their target price on TherapeuticsMD from $8.00 to $6.00 and set a “buy” rating on the stock in a research note on Tuesday, June 11th. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $9.16.

In other TherapeuticsMD news, Director Angus C. Russell purchased 35,000 shares of the stock in a transaction on Thursday, August 15th. The stock was acquired at an average price of $2.83 per share, with a total value of $99,050.00. Following the completion of the acquisition, the director now owns 73,500 shares in the company, valued at $208,005. The acquisition was disclosed in a filing with the SEC, which is available at this link. Also, CEO Robert G. Finizio purchased 52,405 shares of the stock in a transaction on Friday, August 9th. The stock was acquired at an average cost of $2.96 per share, with a total value of $155,118.80. Following the acquisition, the chief executive officer now owns 18,166,559 shares of the company’s stock, valued at approximately $53,773,014.64. The disclosure for this purchase can be found here. In the last three months, insiders acquired 170,549 shares of company stock valued at $493,167. Corporate insiders own 18.91% of the company’s stock.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a women’s health care product company in the United States. The company’s hormone therapy drug candidate is the TX-002HR, a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil. Its preclinical projects include the development of TX-005HR, a topical progesterone cream; TX-006HR, an estradiol and progesterone topical cream to penetrate human skin; and TX-00THR and TX-0008HR, which are transdermal patch forms.

Recommended Story: What are retained earnings?

Want to see what other hedge funds are holding TXMD?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TherapeuticsMD Inc (NASDAQ:TXMD).

Institutional Ownership by Quarter for TherapeuticsMD (NASDAQ:TXMD)

Receive News & Ratings for TherapeuticsMD Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for TherapeuticsMD and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Observing the Projections for CrowdStrike Holdings Inc. (:CRWD) as Shares Tick $69.66

Investors might be trying to gauge which way shares of CrowdStrike Holdings Inc. (:CRWD) will swing over the next couple of quarters. In recent …

Investors might be trying to gauge which way shares of CrowdStrike Holdings Inc. (:CRWD) will swing over the next couple of quarters. In recent trading activity, the stock has been seen near the $69.66 level. Many investors pay increased attention to shares when they are nearing notable historical highs or lows. Over the past 52 weeks, the stock has touched a high price of 99.65, and seen a low price of 58. Looking at some additional historical stock price information, we note that shares have seen a move -6.93% over the previous 12 weeks. If we pull in closer to look at performance over the past month, we see that shares have seen a change of -25.63%. Over the last 5 trading sessions, the stock has moved -19.79%. Investors will most likely be keeping their eyes peeled to see how the stock performs heading into the next round of earnings reports.

Investors might be trying to figure out the best way to approach the stock market. After creating a plan that includes a list of stocks to purchase, investors may be looking to gauge the best time to enter the trade. With markets still cruising along at high altitudes, investors may be worried about buying at the top. Most individuals would probably agree that getting out before the market drops would be the best play. Obviously this is much easier said than done. If the warning signs were blatant, everyone would know exactly when to sell and when to re-buy. When the stock market has a big decline, the natural instinct is generally to sell in order to protect gains or eliminate further losses. Trying to time the market can have negative implications for investors who are not prepared to handle extremely volatile market conditions. Being prepared for any sudden change in the overall economy or stock market conditions may help the investor stay afloat for the long haul.

Following some earnings data for CrowdStrike Holdings Inc. (:CRWD), we note that the current quarter EPS consensus estimate is -0.12. This EPS estimate is using data provided by 8 sell-side analysts polled by Zacks Research. This consensus estimate may vary from other data outlets providing consensus projections. Last quarter, the company reported a quarterly EPS of -0.18. Investors often pay extra close to the actual numbers when they are reported. If the actual comes in way under what the analysts were predicting, investors might want to take a deeper look to see what is going on with the stock. Investors may also be on the lookout for positive surprises on earnings beats. When a company reports actual earnings results, the surprise factor may cause the stock price to move sharply in either direction. Because it is difficult to gauge how a stock will react after the earnings report, investors may trade with increased caution during this period of time.

Investors tracking shares of CrowdStrike Holdings Inc. (:CRWD) may be closely following analyst price target estimates. Reviewing company shares, we can see that the current average target price is 87.71. Keeping track of all the day to day stock market happenings can sometimes be a burden, even for the most seasoned investors. Investors may use sell-side analyst target estimates to help figure out if their assumptions about the future direction of a particular stock price are shared. Of course, nobody can project the future stock price of a company with exact precision. Investors may use analyst target prices as a good starting point for comparing current stock prices and making educated projections themselves.

Stock market investors are typically searching for solid quality companies to help boost the portfolio. There are plenty of quality companies out there, the tricky part may be determining what constitutes as quality. Many investors look for companies that are solid sales leaders within a market that is growing. Going further, investors may be studying a company’s proven track record and gauging the competence of current management. Adding other factors such as brand recognition and prospects for steady growth, investors may eventually find a company that is worth taking the risk for future returns.

After a recent stock review, we can see that CrowdStrike Holdings Inc. (:CRWD) currently has an average broker rating of 1.64. Based on analysts polled by Zacks Research, this rating lands on an easy to follow scale from 1 to 5 where a 1 would indicate a Strong Buy and a 5 would represent a Strong Sell recommendation. Sell-side analysts often provide recommendations for stocks that they regularly cover. Different institutions may use various terminologies for how they describe their ratings. Because individual analyst ratings can vary, investors may choose to follow the average in order to track the general sell-side sentiment. Looking a little further, we can see that 10 polled analysts currently have the stock rated as a Strong Buy or Buy.

Successful investors are usually adept at expecting and reacting to sudden change. Things may be all roses when the markets are riding the bulls higher, but environments shift and can leave investors suddenly in the lurch. When times are good, investors may be well served by maintaining a watchful eye on the portfolio. Becoming complacent when everything seems to be working can become a disaster very quickly without the proper attention. Setting up a plan for different market scenarios can greatly benefit the investor. Routinely studying portfolio contents may help when the need to release some underperformers comes. Keeping close tabs on the portfolio may also help fend off a personal panic if events take a dramatic turn for the worse.

One way to completely avoid market mistakes is to not invest at all. Of course, that could end up to be the greatest mistake of all. Investors will occasionally make some mistakes, as that comes with the territory. The key as with most things in life is to figure out how to learn from past mistakes and use that knowledge to make better decisions going forward. Pinpointing exactly what went wrong may help shed some light on what needs improvement. Sometimes, investors will suffer losses and become discouraged right out of the gate. The tendency is to then try to recoup losses by taking even bigger risks which can lead to complete disaster. One of the biggest differences between successful investors and failed investors is the willingness and ability to learn from past personal mistakes.

Related Posts:

  • No Related Posts

SoftBank expected to buy WeWork shares worth $750M in IPO: Report

Japanese technology Opens a New Window. company SoftBank Group Corp. is planning to buy $750 million of the shares in WeWork’s upcoming …

Will WeWork still go public?

Verdence Capital Advisors’ Kevin Kelly discusses WeWork’s IPO dropping to $10 billion. Apple stock decreases after Goldman cut its target price to $165.

Japanese technology company SoftBank Group Corp. is planning to buy $750 million of the shares in WeWork’s upcoming initial public offering, according to a new report.

Continue Reading Below

We Company’s offering is also expected to raise at least $3 billion, according to The Wall Street Journal, which cited people familiar with the matter.

By buying the shares, SoftBank would have at least 25 percent of the shares in We’s offering. The company is already We’s biggest investor, according to The Journal.

MORE ON FOXBUSINESS.COM…

With SoftBank’s buy-in, We would be valued between $15 billion and $20 billion, which is much lower than the $47 billion that We was valued at earlier this year when SoftBank had previously bought in, the newspaper reported.

Advertisement

However, there is no guarantee the company will be able to achieve its anticipated valuation or that it will be able to pull off its offering, sources told The Journal.

Ticker Security Last Change %Chg
SFTBY SOFTBANK GROUP 22 +0.32 +1.48%

The most recent report comes after an earlier announcement that We has chosen to list its shares on the Nasdaq exchange and plans changes in its governance.

The workspace provider will reportedly begin officially marketing the shares to investors next week ahead of a trading debut the week of Sept. 23, according to The Wall Street Journal.

The company is also expected to set a preliminary price range by next week.

An issue being discussed involved curbing the voting power of founder Adam Neumann, according to a Reuters report.

Neumann has 20 times the voting power of ordinary shareholders.

CLICK HERE TO READ MORE ON FOX BUSINESS

This comes at a time when IPO demand is surging for companies who show they are on a path to profitability, according to the Journal, adding that the roughly 50 percent drop in valuation would hurt investors who have given or committed to over $10 billion to the company.

The company, which was founded in 2010, filed paperwork in August to go public.

FOX Business’ Ken Martin and Daniella Genovese contributed to this article.

Related Posts:

  • No Related Posts

iRobot Corporation (NASDAQ:IRBT): Going Behind the Numbers

Keeping an eye on shares of iRobot Corporation (NASDAQ:IRBT), we see that the current average price target is $86. Wall Street analysts have the …

Keeping an eye on shares of iRobot Corporation (NASDAQ:IRBT), we see that the current average price target is $86. Wall Street analysts have the ability to produce price target estimates for where they think the stock is heading. Because price target projections vary from one analyst to another, they may span a wide range of values. Many investors choose to monitor target prices, and they will pay extra close attention when there are updates. Investors might choose to lean heavily on analyst reports and target projections when doing their own stock research.

Successful investors are typically highly knowledgeable when it comes to the stock market. Smart investors are usually able to know when to buy and when to sell. They are also adept at controlling risk and properly managing the portfolio to extract maximum profit. These types of investors have most likely put in the required time and effort that it takes to understand the inner workings of the market. Expecting that profits will start rolling in immediately can lead to extreme disappointment down the line. Investors have to learn how to align goals and expectations in order to confidently navigate the market terrain.

Street analysts often provide stock recommendations for companies that they track. According to analysts polled by Zacks Research, the current average rating on shares of iRobot Corporation (NASDAQ:IRBT) is 2.5. This average rating includes analysts who have given Buy, Sell and Hold ratings on the name. This rating uses a numerical scale from 1 to 5. A 1 would indicate a Buy recommendation, and a score of 5 would point to a Sell recommendation. Out of all the analysts offering recommendations, 2 have rated the stock a Strong Buy or Buy.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.

Covering analysts are looking for iRobot Corporation (NASDAQ:IRBT) to report a current quarter EPS of 0.58 when the company issues their next earnings report. This is the consensus estimate using analysts taken into consideration by Zacks Research. This estimate includes 5 sell-side analysts. For the previous reporting period, the company posted a quarterly EPS of 0.25. Investors will be closely tracking how close the actual comes to the consensus estimate after the next report. Analysts covering the stock are usually very busy during earnings periods. Before the release, they might be revising estimates. After the earnings release, they will closely review the information and update accordingly.

Looking at some recent stock price activity for iRobot Corporation (NASDAQ:IRBT), we have spotted shares trading near the $65.66 level. Looking at some popular historical levels, we note that the 52-week high is presently $130.78, and the 52-week low is currently $60.23. When the stock is trading close to the 52-week high or 52-week low, investors may pay extra attention to see if there will be a move through that level. Looking back over the last 12 weeks, the stock has moved -29.14%. Heading back to the start of the year, we can see that shares have moved -21.3%. Over the past 4 weeks, shares have seen a change of 1.97%. Over the last 5 trading sessions, the stock has moved 9.41%.

The stock market can be an exciting yet scary place for investors who are just starting out. Individual investors who decide to manage their own portfolios may need to hit the books and be ready to take a comprehensive approach. There is no lack of information about investing in the stock market, but figuring out where to start can be difficult. Setting up goals and defining the investment plan can help start the investor down the right path. As many seasoned investors know, there can be times when nothing seems to be going right. Keeping a clear head and focusing on the relevant information can help the investor stay steady when the going gets tough.

WeWork makes sweeping corporate governance changes in advance of its IPO

Instead, 32.6 million are held by venture capital firm Benchmark Capital Partners and its chief Bruce Dunlevie, a WeWork director. Those super voting …

WeWork’s parent company said Friday it would make substantial changes to the oversight of its business after investors voiced dissatisfaction with the unusual governance structure ahead of a planned IPO.

Among the biggest changes, the super voting shares of We Co. won’t be quite as super as originally planned. WeWork’s parent company had originally proposed that 20 votes for each share of Class A stock given to the company’s founders and early investors. Now they will have 10 votes each, according to a regulatory filing in advance of its planned initial public offering.

Those extra votes would completely vanish, becoming only a single vote, if CEO and co-founder Adam Neumann, 40, dies or becomes incapacitated.

Neumann has 2.4 million of those shares, but that’s not a majority. Instead, 32.6 million are held by venture capital firm Benchmark Capital Partners and its chief Bruce Dunlevie, a WeWork director. Those super voting shares will still collectively have majority control of the company.

Another major change in corporate governance in Friday’s filing is how Neumann’s successor would be named.

Previously, in the event that Neumann were to die or become incapacitated in the 10 years following the IPO, the decision on a successor would have rested with a committee formed by his wife Rebekah Neumann, who is not a director of the company, along with two directors. Those plans raised many concerns among corporate governance experts. Now the plan is simply for the board of directors to pick a successor, as is typically the case with public companies.

“We will not rely on a succession committee. Our board has the ability to remove our chief executive officer,” said the filing.

The filing also now promises that “No member of Adam’s family will sit on our board.”

The filing comes amid a flurry of reports that the company may delay or even scrap its public offering plans. There was also signs that the company’s valuation will be reduced, although that estimated value was not spelled out in Friday’s filing.

The company is considering seeking a valuation in the $20 billion range for its planned IPO, according to the Wall Street Journal, which was first to report the news Thursday. The company was previously valued at as much as $47 billion on the private market, according to CB Insights, a research firm that tracks venture capital. But some other high profile tech stocks, such as Uber and Lyft, have struggled since their IPO filings this year, suggesting investors’ appetite for money-losing tech companies isn’t what it used to be.

The company is fast growing. Its revenue of $1.5 billion in the first half of this year is more than double what it brought in during the same period of 2018, and up about 250% from what it brought in during all of 2016. But its losses have also soared, reporting a net loss of $904 million in just the first six months of this year and a total of $4.2 billion since the start of 2016.

When We Co. filed its paperwork last month to go public, it set off a wave of criticism around the company centered on everything from its staggering losses to its lack of a woman on its board to the unchecked power of its CEO.

In response, the company announced several updates in early September, including that it would add its first female board member, Harvard Business professor Frances Frei, upon completion of its IPO. It also said Adam Neumann would repay the company $5.9 million in stock that his holding company, WE Holdings LLC, received after selling off its trademark of the word “We” to The We Company. In January, WeWork rebranded itself as The We Company to serve as an umbrella company to its various businesses.

The New York-based company was founded in 2010 as WeWork by Neumann and Miguel McKelvey, who is chief culture officer. It offers coworking spaces in more than 100 cities around the world and ranks as one of the most valuable privately-held companies in the US. Investors have poured billions of dollars into the company and its incredibly broad — arguably vague — selling point of “community.”

“We are a community company committed to maximum global impact,” the company described itself in its IPO prospectus. “Our mission is to elevate the world’s consciousness.”

Some have raised concerns about the sustainability of its core business, WeWork, in the event of an economic downturn. In its IPO filing, WeWork addresses how certain factors, such as declines in market rents, inability to negotiate satisfactory leases, or membership retention, could impact its business.

We Co. also announced Friday it would list on the Nasdaq stock exchange.

This content was republished with permission from CNN.

Related Posts:

  • No Related Posts